Marini D, Agnoletti G
Regina Margherita Child Hospital, Turin, Italy.
Minerva Cardioangiol. 2010 Feb;58(1):79-96.
During the last 10 years the interventional treatment of congenital and structural heart diseases has known enormous changes in techniques, methods and patients management. Lesions previously treated surgically are now approached in the catheterization laboratory. The advent of multidisciplinary approach of congenital heart disease has made possible the development of hybrid techniques, of fetal medicine and of magnetic resonance imaging (MRI)- guided cardiac catheterization. Technological innovation has introduced new concepts in treatment of congenital heart disease patients and has allowed to adapt different techniques to single patients. The knowledge of the evolution of structural heart disease has allowed to chose the best percutaneous and/ or surgical technique and the best materials to optimize long term results. Improvement in non invasive imaging modality has allowed to diminish the radiation exposure and to provide useful information to interventional cardiologists and cardiac surgeons. Absorbable, drug eluting tools will change the treatment and probably the natural history of congenital and structural cardiac and vascular diseases.
在过去十年中，先天性和结构性心脏病的介入治疗在技术、方法及患者管理方面发生了巨大变化。以前通过手术治疗的病变现在可在导管室进行处理。先天性心脏病多学科治疗方法的出现使得杂交技术、胎儿医学以及磁共振成像（MRI）引导下的心导管插入术得以发展。技术创新为先天性心脏病患者的治疗引入了新观念，并使不同技术能够适用于个体患者。对结构性心脏病演变的了解有助于选择最佳的经皮和/或手术技术以及最佳材料，以优化长期治疗效果。无创成像方式的改进减少了辐射暴露，并为介入心脏病学家和心脏外科医生提供了有用信息。可吸收、药物洗脱工具将改变先天性和结构性心脏及血管疾病的治疗方式，甚至可能改变其自然病程。
